Effect of SGLT2 inhibition on glucosuria during a hyperglycemic clamp in HNF1A-MODY (MODY3) and type 2 diabetes
Maagensen H, Jensen JS, Høyerup SO, et al.
Diabetes Care. 2025:dc250737.
Leggi
Maagensen H, Jensen JS, Høyerup SO, et al.
Diabetes Care. 2025:dc250737.
Leggi
Beese SE, Price MJ, Tomlinson C, et al.
BMC Med. 2025;23(1):351.
Leggi
Vähäkangas E, Saarimäki-Vire J, Montaser H, et al.
Diabetologia. Pub. online 2 Jul 2025.
Leggi
04/07/2025
Leggi
Kermansaravi M, Omar I, Finer N, et al.
BMC Endocr Disord. 2025;25(1):151.
Leggi
30/06/2025
Leggi
27/06/2025
Leggi
04/07/2025
Leggi
Zambon A, Gentile L, Galimberti F, et al.
Nutr Metab Cardiovasc Dis. Pub. online 28 Jun 2025.
Leggi
Vallivaara HL, Leppänen HA, Mustonen J, et al.
Diabetes Obes Metab. Pub. online 27 Jun 2025.
Leggi